Lilly takes 6 companies to court for selling retatrutide knockoffs
Eli Lilly Sues Six Companies Over Alleged Retatrutide Knockoffs Eli Lilly and Company has filed lawsuits against six companies accused of manufacturing, marketing, or distributing unauthorized versions of retatrutide, the pharmaceutical giant's investigational triple-hormone receptor agonist that h...
Read Full ArticleAll News
Australian TGA Personal Importation Scheme: Can You Legally Import Peptides?
Australian TGA Personal Importation Scheme: Can You Legally Import Peptides? Australians seeking to import research peptides and growth hormone secretagogues for personal use face a significant legal obstacle: the Therapeutic Goods Administration's (TGA) Personal Importation Scheme, widely believed...
BPC-157 Legal Status in Australia: TGA Regulations Explained
Overview of the Regulatory Action BPC-157, a synthetic peptide derived from a fragment of a protein found in human gastric juice, has become one of the most searched-for compounds in the peptide and performance-enhancement communities worldwide.
Australia Peptide Laws: TGA Regulations, Import Rules, and Scheduling
An analysis of Australian peptide laws covering TGA scheduling, import restrictions, and how the regulatory framework compares to the US and UK.
Will Compounded Semaglutide Become Illegal? Patent Law Explained
With Novo Nordisk's semaglutide patents extending into the 2030s, consumers wonder if compounded versions will be banned. We explain how patent law, FDA shortage rules, and pharmacy regulations determine compounded semaglutide's legal future.
Can Peptide Companies Legally Make Health Claims? FDA and FTC Rules
Peptide sellers frequently make bold health claims, but most violate FDA and FTC regulations. Learn what companies can legally claim about peptides and how illegal marketing puts consumers at risk.
Peptide Therapy Side Effects: Your Legal Rights If Something Goes Wrong
When peptide therapy causes harm, patients often don't know their legal options. Learn about liability for peptide therapy injuries, when you can sue, and how to protect your rights if you experience adverse reactions.
Tirzepatide Compounding: Legal Gray Areas Explained
In recent years, the compounding of peptides like Tirzepatide has become a topic of significant debate and intrigue within the pharmaceutical and healthcare industries.
Research Peptide Disclaimers: Do They Provide Legal Protection?
In recent years, research peptides have gained significant attention within the scientific community, offering promising avenues for medical advancements and therapeutic interventions.
WADA and Sports Law: Peptides in Athletic Competition
The intersection of athletic competition and pharmacological enhancement has been a focal point of sports law and ethics for decades.
Personal Importation of Peptides: FDA Guidelines and Risks
The world of pharmaceuticals is evolving, with peptides gaining significant attention in recent years due to their therapeutic potential.
The Legal Status of BPC-157: Not FDA Approved But Not Illegal?
In the rapidly evolving landscape of peptide research and application, BPC-157 stands out as a compound of significant interest. Despite its growing popularity, its legal status remains a topic of debate and confusion.